ClinicalTrials.Veeva

Menu

Spatially Transcriptomics Reveals Molecular Signatures in CRPS

S

Seoul National University

Status

Enrolling

Conditions

Complex Regional Pain Syndromes

Study type

Observational

Funder types

Other

Identifiers

NCT05986461
2304-052-1421

Details and patient eligibility

About

This observational study aims to understand phenotype-specific molecular signatures in patients with complex regional pain syndrome (CRPS).

Full description

Participants who meet the diagnostic criteria for CRPS, aged 19~80 years, and agree to participate in this study will undergo a 4mm-sized skin punch biopsy in the involved limb, as well as the contralateral side (internal control).

Spatial transcriptomics will be used to identify immune cell signatures and differentially regulated genes (DEGs) in the epidermis, vasculature, sweat gland, and nerve plexus of the involved ipsilateral (vs contralateral) side of the patient's skin.

Enrollment

10 estimated patients

Sex

All

Ages

19 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meets the Budapest diagnostic criteria
  • Consents to participation in this study
  • Aged between 19 and 80 years old
  • Symptoms and/or signs of sensory, vasomotor, and sudomotor changes

Exclusion criteria

  • Who do not agree to participate in this study
  • Who has contraindications for skin punch biopsy (e.g. thrombocytopenia, taking anticoagulant drugs)

Trial contacts and locations

1

Loading...

Central trial contact

Jeongsoo Kim, MD; Jee Youn Moon, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems